Microencapsulation of pancreatic islets has been proposed as a means to prevent allograft rejection and to protect islets during cryopreservation. The aim of this study was to investigate: 1) the effects of the cryoprotectants (CPAs) dimethyl sulfoxide (DMSO) and ethylene glycol (EG) on the volume of Ca 2+ alginate micro capsules, and 2) the effects of microencapsulation on the volumetric response of human and canine pancre atic islets during CPA equilibration. Stock sodium alginate with a high mannuronic acid content (HM) or a high guluronic acid content (HG) was used to generate empty capsules (mean diameter 200 pm) with an electrostatic generator. The capsules were held in place by a holding pipette system and videotaped during the addition of 2 or 3 M CPA at 22°C. Islets (isolated from human cadaveric donors and mongrel dogs and then cultured overnight at 37°C) were encapsulated in alginate (HM), loaded into a microperfusion chamber, and the change in islet volume was videotaped after exposure to the same CPAs and concentrations. These were compared to the volume responses of nonencapsulated islets. Images were analyzed using a computer ized image analysis system and the data were analyzed using ANOVA. HG microcapsules showed a signifi cant (p < 0.05) increase in volume following exposure to EG but not to DMSO. HM microcapsule volume did not change significantly following exposure to either EG or DMSO and was therefore chosen as the substrate for islet encapsulation. Free, nonencapsulated canine and human islets responded to the osmotic challenge of the 2 M DMSO by shrinking to 70.00 ± 1.04% (mean ± SEM) and 70.11 + 1.05%, and in 2 M EG to 72.89 ± 1.93% and 69.33 ± 1.38%, respectively, of the isotonic volume before returning to the original cell volume. Exposure to 3 M DMSO or EG resulted in a further dehydration to 65.89 ± 0.91.% and 67.67 ± 1.91 % for canine and 62.22 ± 0.66.% or 65.89 + 1.30% for human islets. Minimum volumes were reached within 30-40 s after exposure to the cryoprotectant. Encapsulated human islets reached 86.88 ± 1.47% of their original volume in 2 M and 80.33 ±0.89% in 3 M DMSO, and 87.33 ± 1.86% in 2 M and 82.80 ± 1.57% in 3 M EG. This volume change was significantly less (p < 0.01) than that observed in corresponding free islets. Encapsulated canine islets reached 83.67 ±2.13% of their original volume in 2 M and 78.22 ± 0.95% in 3 M DMSO, and 85.44 ± 1.92% in 2 M and 78.11 ± 2.01% in 3 M EG. As with human islets, this was significantly different than free islets (p < 0.01). These minimal volumes were reached within 30-50 s. These results demonstrate that there are cryoprotectant and alginate-specific interactions and that microen capsulation modulates the degree of osmotically induced shrinkage of islets. The development or modifica tion of existing cryopreservation protocols to improve postcryopreservation recovery or function must ac count for these factors.
INTRODUCTION
detrimental to the patient than the actual disease. In the ory, transplantation of islets of Langerhans inside semi permeable membranes could create an immunological barrier between the host and the transplanted tissue and thus avoid the necessity of immunosuppresive drugs (3) . Indeed, since the first report of successful immunoisola tion and transplantation of islets by Lim and Sun (15) , there have been many promising studies evaluating sys-tems such as alginate microencapsulation (coated and uncoated), hollow fiber techniques, and arteriovenous shunt devices (4, (11) (12) (13) (14) 17, 21) . However, in addition to potentially providing immunoisolation, it has recently been noted that islets microencapsulated in Ca 2+ alginate alone or alginate coated with poly-L-lysine yield higher recovery rates and may even survive cryopreservation much better than nonencapsulated islets (8, 21, 29) .
Although IDDM does not require emergency islet graft availability, a cryopreserved "bank" would add great flexibility to islet transplant programs, and the de velopment of a long-term storage method remains a final logistical impediment to an effective clinical evaluation. (20) . These processing steps result in multiple osmotically induced islet volume fluctuations (16, 25, 28) . Islets initially shrink upon exposure to per meating CPAs (such as DMSO or EG) and then reswell as the CPA penetrates cellular membranes. Islets un dergo a second shrinkage during the equilibrium cooling step as extracellular ice forms, concentrating the remain ing solution and causing cellular exosmosis. Islets once again regain their normal volume following thawing;
however, the removal of CPA causes osmotically in duced swelling (16, 18, 19) .
Although the enhanced survival of microencapsulated vs. free islets following cryopreservaion has been docu mented, the fundamental mechanism(s) by which the system may afford extra protection during (at least) one of the freezing or thawing steps has not been deter
mined. An initial study is presented here that investi gated events occurring in the microcapsule-islet system during the first step of the cryopreservation process:
CPA equilibration. In addition, empirical data regarding the encapsulated islet's ability to respond volumetrically to various osmotically induced challenges were exam ined. This was accomplished by measuring: 1) the ef fects of the CPAs DMSO and EG on uncoated Ca 2+ algi nate microcapsule volume, and 2) the effects of microencapsulation on the osmotically induced volumet ric excursions of human and canine pancreatic islets in response to additions of these same CPAs. In an attempt to further investigate the ability of encapsulated islets to respond volumetrically to changes in solute concentra tion, encapsulated human islets were also exposed to hy perosmotic solutions of a nonpermeating solute (NaCl) to effect nontransient osmotic shrinkage due to water movement out of the intracellular space.
The overall goal of this study was to better under stand how encapsulated islets would respond to osmotic challenges, and how CPAs might interact with or influ ence the microcapsule-islet system. Two variations of the Kedem-Katchalsky formalism (9) were developed in an attempt to describe the encapsulated islet volume re sponses kinetically. The empirical data, however, did not readily conform to this type of analysis. Therefore, mean minimum volumes (and times required to reach minimum volumes) were also determined and used to quantify the data and to allow comparison between en capsulated human or canine islets and previously pub lished data regarding free human and canine islet vol ume responses under similar conditions (26) .
The study evaluated DMSO because of its wide use in islet cryopreservation strategies, and EG due to recent evidence of its possible superiority as a CPA based on permeation studies in canine islets (26) as well as in vitro/in vivo studies involving rat islets (10) . Uncoated alginate microcapsules were chosen based on ease of production and evidence implicating the commonly used poly-L-lysine coating as a major contributing factor for initiating host fibrosis reaction following transplantation (27) .
MATERIALS AND METHODS

Reagents
All tissue culture reagents were obtained from Gibco 
Generation of Microcapsules
Alginate microcapsules ranging from 150 to 300 pm in diameter were produced using a syringe pump in con junction with an electrostatic generator. Sodium alginate by itself (for empty spheres) or mixed with an islet sus pension in isotonic saline was expelled into a solution of calcium chloride to solidify the gel. The microcap sules were then washed in culture medium and incu bated under the same conditions as islets alone.
CPA Perfusion
Empty Microcapsules. Microspheres ranging from 150 to 300 pm in diameter were hand picked under a stereomicroscope (Nikon SMZU-10A, Melvile, NY) and placed in a 20-pl droplet of media centered in a 60-mm petri dish. The spheres were held in place (two at a time) within the droplet by a micropipette system while 3 ml of 2 M DMSO or EG was abruptly added to effect a single-step CPA concentration change. The system was fixed on the stage of an inverted microscope for viewing (Nikon, Tokyo, Japan) ( Fig. 1) . A total of six microcap sules was evaluated for each experimental condition. Volume measurements were taken over time and com pared with equal numbers of microcapsules perfused with CPA-free medium.
Islets and Encapsulated
Islets. Encapsulated islets ranging from 50 to 200 pm in diameter were hand picked under a stereomicroscope (Nikon SMZU-10A) and deposited into a microperfusion chamber developed for islet manipulation and observation (26) . The cham ber was used for these experiments because it allowed more efficient quantification of islets or encapsulated is lets but was unsatisfactory for examining the transparent empty capsules (Fig. 2) . Briefly, encapsulated islets were placed onto a polycarbonate membrane (5 pm pores; Poretics, Livermore, CA) at the bottom of the 20pl chamber that was prefilled with tissue culture me dium. A 650-pl reservoir was filled with the CPA (2 or 3 M DMSO or EG), and a syringe was used to apply negative pressure to the chamber for the abrupt replace ment of 20 chamber volumes of medium with that from the reservoir. The chamber was fixed under an upright compound microscope for viewing (Nikon Optiphot, Tokyo, Japan). Each experimental condition was im posed upon 18 encapsulated islets (9/species) equally distributed among three human or three canine subjects. Encapsulated islets were perfused in the chamber (three at a time) while volume measurements were taken and recorded over time. These data were compared with equal numbers of nonencapsulated islets (from the same subject pool) perfused in the exact manner for use in a separate study (26) .
Nonpermeating Solute Osmotic Challenges
In an attempt to investigate the ability of encapsu lated islets to respond volumetrically to changes in sol ute concentration, encapsulated human tissue was exposed to hyperosmotic solutions in which nonperme ating solute (NaCl) was added to the base medium to reach final concentrations of 600 and 900 mOsm/kg
QQ :
: 09 ELAPSE Figure 1 . Representative image of empty alginate microcapsules held in place us ing the holding pipette method. These images were used to determine volume changes following CPA addition. Both scenarios were considered theoretically through an extension of the Kedem-Katchalsky formalism (9) .
This method has been used successfully to describe non-encapsulated islet kinetic volume response by fitting curves to empirical data, allowing determination of per meability coefficients inherent to the tissue (e.g., hy draulic conductivity, L p ; solute permeability, P,; and re flection coefficient, a) (2, 24, 26) . For the following cases, these parameters were assumed equal to average values determined previously (26) . For canine islets in 2 M DMSO, L p = 0.57 (pm/min/atm), P., = 1.2 (cm/min), where V is islet volume, V"" is the isosmotic islet vol ume, and C y is a proportion coefficient (microcapsule compressibility in units of atnf') that was determined through the curve fit to the data.
Statistical Analysis
Empty microcapsules, free islets, and encapsulated is let minimum or endpoint volume responses were ana lyzed using standard analysis of variance (ANOVA) approaches as implemented by SAS software (SAS in stitute, Cary, NC). Statistical significance was consid ered at the p < 0.05 level.
RESULTS
Effects of CPAs on Empty Microcapsules
The empty alginate microcapsules from either source did not undergo the usual osmotically driven transient volume excursions exhibited by cells and tissues ( Fig.   3 ). Microcapsules generated using the high mannuronic acid content alginate did not change in volume after ad dition of either CPA at either concentration when com pared to controls. Those generated using the high gulur-onic acid alginate increased in volume after addition of 2 or 3 M EG but not DMSO at either concentration when compared to controls ( (Table 2) . As with human islets, this was significantly different from free islets (p < 0.01). These minimal volumes were reached within 30-50 s.
Kinetic Response Modeling.
Free human and canine islets shrank quickly after CPA addition and gradually reswelled as the CPA and water permeated (Fig. 3) .
These kinetic volume excursion histories have pre viously been characterized using the Kedem-Katchalsky formalism (9) describing water and solute permeability, and values for water permeability (L p ), CPA solute per meability (P,), and reflection coefficient (a) have been determined and published for human and canine islets (26) .
Human and canine islets encapsulated in high man nuronic acid alginate exhibited similar kinetic patterns of CPA permeation; however, the degree to which the encapsulated islets shrank was greatly reduced. Encap sulated islets exhibited a kinetic response somewhat similar to free islets (Fig. 3) . In many cases, however, kinetic volume histories were difficult to obtain clearly due to some of the outer layer cells remaining embedded in the Ca 2+ alginate while the remaining internal islet cells shrank in response to the initial osmotic challenge.
Curve fits for encapsulated islet kinetic volume re sponses could not be obtained using the diffusion model.
These data seemed to follow a pattern that could be de- 
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Values are mean ± SEM; n = 9. Level of statistical difference between nonencapsulated vs. encapsulated islet minimum volume is indicated for each case.
scribed to some extent by the mechanical force model ing approach; however, values for the compressibility coefficient determined through curve fitting were ex tremely inconsistent.
Effects of Concentrated Nonpermeable Solute on Encapsulated Islets
The mechanical force exerted by the alginate on en trapped islets was very apparent in these data. In each of the two hyperosmotic solutions (600 and 900 mOsm/ kg), the tissue was given ample time to completely equilibrate through dehydration, based on the published osmotic characteristics of islet tissue (2, 5, 25) . In most cases the structural integrity of the islet seemed compro mised ( Fig. 4) , although the extent of this phenomenon seemed linked to the initial denseness of the tissue, and in the best cases, the islet shrank more or less com pletely from the capsule interior ( Fig. 5 ).
DISCUSSION
The cryopreservation of various cells and tissues has been a topic of interest in many studies over the last several decades, and the investigation and improvement of pancreatic islet cryopreservation has been studied by many groups (1, 20, 23, 26 In the case where islet endpoint volumes could be mea sured with confidence, a clear boundary existed, indicat ing the volume of space the islet occupied at its isosmotic volume (Fig. 5 ). In the typical case, the constituent islet cells broke contact with each other and varying proportions of the outer islet cells remained em bedded in the alginate matrix while interior cells shrank away (Fig. 4) . The extent to which this occurred seemed to be a function of how "loose" the tissue was prior to encapsulation procedures. The sloughing of the exterior cells was not as extensive in tight, compact islets and was more evident in islets that appeared to have been slightly damaged by overdigestion durin" isolation pro cedures.
At the current time, to the best of our knowledge, only three published studies exist regarding microencap sulation of pancreatic islets and cryopreservation sur vival. Of these three, only one focused on uncoated solid Ca 2+ alginate capsules (21) . In that study, higher num bers of microencapsulated, frozen-thawed (using the standard protocol) canine islets were recovered (88% vs.
77% nonencapsulated recovered). These islets were able to normalize and maintain glucose homeostasis in dia betic nude mice. In the other two studies, alginate cap sules that had been coated with poly-L-lysine (to allow liquified cores) were studied in conjunction with cryo preservation of rat or porcine islets using the standard method or a simplified approach (Nalgene® cell freezer box without induced ice nucleation) (8, 29) . In the study regarding rat islets, 97% recovery was achieved, and transplantation of islets frozen with the standard or sim plified protocol into diabetic mice both resulted in prompt return to normoglycemia within 24 h. In the por cine encapsulated islet study, 97% recovery was also re ported; however, only batches frozen using the standard protocol were able to respond effectively to glucose challenges in vitro (these were also adequate to render diabetic mice euglycemic following transplant). Obvi ously, the most striking similarity among all three stud ies is the high numbers of islets recovered following the cryopreservation process. It is important to note that islet recoveries are typically quantified using a system that divides islets into categories based on 50-pm increments ranging from 50 to 250+ pm diameters. A conversion factor is then applied to determine the equivalent num ber of 150-pm-diameter islets in the preparation (22) .
Islets smaller than 50 pm in diameter are usually not counted. After cryopreservation it is not uncommon for large islets to break into smaller fragments, usually smaller than the scoring cutoff. This is especially true of porcine islets, which tend to fragment even without cryopreservation, and commonly fragment completely if cryopreserved without microencapsulation (29) . It is likely that this ability to prevent fragmentation is a rea son for the enhanced recovery and function of microen capsulated islets following cryopreservation.
In the present study, it was found that the rigid nature of solid alginate capsules inhibited free islet volumetric responses. It is not known how this would exactly affect the ability of the entrapped tissue to respond to glucose challenges in vivo; however, gross physical damage can be observed (e.g., rupture of cell-cell contacts) after ex posure to anisosmotic solutes within the tolerable range of nonencapsulated islets. The coated alginate systems, in which the core is reliquefied, would most likely effect less of an inhibition of the required islet volumetric re sponses during cryopreservation. This may be especially important when considering porcine islets, which, unlike other models (e.g., rat, canine, and human), are very loose structurally to begin with and therefore may be even more susceptible to the problems witnessed in the canine and human islets presented here.
